Pyridinylimidazole based p38 MAP kinase inhibitors.

Current topics in medicinal chemistry

Volumn 2, Issue 9, 2002, Pages 1011-1020

  Jackson, Paul F ^a   Bullington, James L ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; INDOLE; INDOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL; ARTHRITIS; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; INDOLES; MITOGEN-ACTIVATED PROTEIN KINASES; OXAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0036715931     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026023393372     Document Type: Review

References (45)